Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$114M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$31.3M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$26.4M |
| 4 |
Tyler Technologies
TYL
|
+$25M |
| 5 |
Brown & Brown
BRO
|
+$18.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$249M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Alibaba
BABA
|
+$140M |
| 5 |
Amazon
AMZN
|
+$99.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.7% |
| 2 | Healthcare | 14.91% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Communication Services | 10.34% |
| 5 | Industrials | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Sunrun
RUN
$2.42B
| $2.02M | ﹤0.01% |
146,350
+5,900
| +4% | +$88K |
|
|
AERI
1727
DELISTED
Aerie Pharmaceuticals
AERI
| $2.02M | ﹤0.01% |
83,500
+1,600
| +2% | +$33.1K |
|
|
NVMI
1728
Nova
NVMI
$13.3B
| $2.02M | ﹤0.01% |
53,078
+1,133
| +2% | +$39.7K |
|
1729
Tronox
TROX
$945M
| $2.02M | ﹤0.01% |
176,600
-5,500
| -3% | -$55K |
|
1730
The Greenbrier Companies
GBX
$1.4B
| $2.01M | ﹤0.01% |
62,100
+1,300
| +2% | +$38.9K |
|
1731
Herc Holdings
HRI
$5.78B
| $2.01M | ﹤0.01% |
41,146
+900
| +2% | +$42K |
|
1732
Middlesex Water
MSEX
$1.1B
| $2.01M | ﹤0.01% |
31,662
+800
| +3% | +$50.7K |
|
|
REGI
1733
DELISTED
Renewable Energy Group, Inc.
REGI
| $2.01M | ﹤0.01% |
74,600
+5,200
| +7% | +$94.3K |
|
1734
Usana Health Sciences
USNA
$248M
| $2M | ﹤0.01% |
25,500
-900
| -3% | -$66.3K |
|
1735
Heritage Financial
HFWA
$1.22B
| $2M | ﹤0.01% |
70,568
+1,300
| +2% | +$35.9K |
|
1736
National Bank Holdings
NBHC
$1.94B
| $1.99M | ﹤0.01% |
56,600
+1,400
| +3% | +$49.4K |
|
|
AKS
1737
DELISTED
AK Steel Holding Corp
AKS
| $1.99M | ﹤0.01% |
605,600
+17,100
| +3% | +$47.4K |
|
|
AVX
1738
DELISTED
AVX Corporation
AVX
| $1.99M | ﹤0.01% |
97,100
+2,900
| +3% | +$49.9K |
|
1739
Range Resources
RRC
$9.44B
| $1.98M | ﹤0.01% |
409,100
+9,500
| +2% | +$38.3K |
|
1740
3D Systems Corp
DDD
$615M
| $1.98M | ﹤0.01% |
226,150
+7,100
| +3% | +$61.6K |
|
1741
Lindsay Corp
LNN
$1.17B
| $1.98M | ﹤0.01% |
20,600
+300
| +1% | +$27.4K |
|
1742
Parsons
PSN
$5.1B
| $1.97M | ﹤0.01% |
+47,600
| New | +$1.78M |
|
|
BAND
1743
Bandwidth Inc
BAND
$1.72B
| $1.96M | ﹤0.01% |
30,600
+2,600
| +9% | +$151K |
|
|
EBSB
1744
DELISTED
Meridian Bancorp, Inc.
EBSB
| $1.95M | ﹤0.01% |
97,000
+1,400
| +1% | +$27.4K |
|
|
CARO
1745
DELISTED
Carolina Financial Corp.
CARO
| $1.95M | ﹤0.01% |
45,000
+5,400
| +14% | +$213K |
|
1746
Artivion
AORT
$1.42B
| $1.94M | ﹤0.01% |
71,700
+1,800
| +3% | +$44.2K |
|
|
BPFH
1747
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $1.93M | ﹤0.01% |
160,700
+3,300
| +2% | +$38.3K |
|
|
GPMT
1748
Granite Point Mortgage Trust
GPMT
$56.9M
| $1.93M | ﹤0.01% |
104,977
+4,100
| +4% | +$75.2K |
|
1749
WillScot Mobile Mini Holdings
WSC
$4.36B
| $1.92M | ﹤0.01% |
104,000
+3,000
| +3% | +$50.4K |
|
1750
Innoviva
INVA
$1.53B
| $1.92M | ﹤0.01% |
135,700
+2,600
| +2% | +$31.9K |
|
Similar funds
Swiss National Bank's Q4 2019 Portfolio in Review
As of Q4 2019, Swiss National Bank held 2,602 positions worth $97.5B, up 3.6% from $94.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Swiss National Bank withdrew a net $3.98B in Q4 2019, closing 96 positions and reducing 725 holdings. Its most notable exit was Celgene Corp, an estimated $231M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Match Group worth $14.7M.
- Swiss National Bank's largest Q4 2019 buy was Match Group: 179,200 shares worth $14.7M.
- Swiss National Bank added most to Bristol-Myers Squibb in Q4 2019, an estimated $114M increase.
- Swiss National Bank's biggest Q4 2019 reduction was Apple, cutting an estimated $249M.
- Swiss National Bank fully exited Celgene Corp in Q4 2019, selling an estimated $231M.
- Swiss National Bank's ten largest holdings make up 19% of its $97.5B portfolio in Q4 2019.
- Swiss National Bank opened 82 new positions and closed 96 in Q4 2019.
- Swiss National Bank's portfolio value rose 3.6% quarter-over-quarter to $97.5B.
Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.